Condition

Irritable bowel syndrome

IBS news when it appears alongside Crohn's disease, IBD, symptom overlap, diagnosis, or patient-facing digestive health updates.

32 articles

Vitamin D and Intestinal Diseases: Impact on Intestinal Immunity and Gut Barrier Function
Diseases

Vitamin D and Intestinal Diseases: Impact on Intestinal Immunity and Gut Barrier Function

Vitamin D appears linked to immune regulation, gut barrier health, and the microbiome—processes relevant to IBD and other intestinal disorders. Understanding this could affect how clinicians monitor and study vitamin D...

Read Summary
Mistakes in the management of irritable bowel syndrome-diarrhoeal subtype and mimics: a narrative review.
Current medical research and opinion

Mistakes in the management of irritable bowel syndrome-diarrhoeal subtype and mimics: a narrative review.

People labelled with IBS-D may actually have treatable organic conditions that require different tests and treatments; avoiding diagnostic mistakes can speed appropriate care and reduce unnecessary symptom-focused...

Read Summary
From Dysbiosis to systemic health: Microbiome modulation as a unified therapeutic framework.
Acta microbiologica et immunologica Hungarica

From Dysbiosis to systemic health: Microbiome modulation as a unified therapeutic framework.

The review connects microbiome-targeted therapies (diet, probiotics, FMT, antibiotics, and newer approaches) to mechanisms relevant to IBD and systemic health, highlighting why these strategies are of interest to...

Read Summary
Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design.
Materials today. Bio

Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design.

IBD and other lower-GI disorders may benefit from oral hydrogel platforms that improve local drug delivery while deliberately engaging the gut microbiota. Understanding this research direction helps patients and...

Read Summary
A Novel Human Intestinal Organoid Platform with Peristaltic Function for Drug Discovery and Pre-Clinical Testing in GI Motility Disorders
NIH RePORTER

A Novel Human Intestinal Organoid Platform with Peristaltic Function for Drug Discovery and Pre-Clinical Testing in GI Motility Disorders

A validated human peristaltic intestinal organoid model could make preclinical testing more predictive for drugs affecting gut motility and reduce reliance on animal models.

Read Summary
Dietary patterns, gut microbiota, and gastrointestinal disorders: mechanistic insights into irritable bowel syndrome and inflammatory bowel disease.
Reviews on environmental health

Dietary patterns, gut microbiota, and gastrointestinal disorders: mechanistic insights into irritable bowel syndrome and inflammatory bowel disease.

Diet is a modifiable factor that appears to change the gut microbiome and may affect symptoms and inflammation in both IBS and IBD; understanding which patterns help could guide practical dietary advice.

Read Summary
Gut microbiome in pediatric acute pancreatitis and Crohn's disease versus irritable bowel syndrome and healthy controls
Journal of Pediatric Gastroenterology and Nutrition

Gut microbiome in pediatric acute pancreatitis and Crohn's disease versus irritable bowel syndrome and healthy controls

The gut microbiome differed more in pediatric Crohn’s disease and acute pancreatitis than in IBS or healthy kids, suggesting microbial changes are stronger in organic inflammatory disease and could be targets for future...

Read Summary